Showing results (21-30 of 32) with videos related to
Sort By:
Pageof 4
Neuropharmacology|February 1, 1992
Effects of prolonged administration of milnacipran, a new antidepressant, on receptors and monoamine uptake in the brain of the ratM B Assie, M Charveron, C Palmier, et al.Bioorganic & Medicinal Chemistry|November 5, 1998
5-(Sulfonyl)oxy-tryptamines and ethylamino side chain restricted derivatives. Structure-affinity relationships for h5-HT1B and h5-HT1D receptorsT Barf, H Wikström, P J Pauwels, et al.Atherosclerosis|July 1, 1981
Differential effects of itanoxone--a new hypolipidemic and hypouricemic drug--on platelet and vascular prostaglandin generation in ratsM Livio, C Palmier, S Villa, et al.Atherosclerosis|April 1, 1981
Plasma viscosity and biochemical parameters in the "fatty" ratJ F Stoltz, S Gaillard, A Dehlon, et al.Journal of Medicinal Chemistry|December 16, 1997
5-HT1B receptor antagonist properties of novel arylpiperazide derivatives of 1-naphthylpiperazineC Jorand-Lebrun, P J Pauwels, C Palmier, et al.Bioorganic & Medicinal Chemistry Letters|January 5, 1999
Design and synthesis of new potent, silent 5-HT1A antagonists by covalent coupling of aminopropanol derivatives with selective serotonin reuptake inhibitorsM Perez, P J Pauwels, I Pallard-Sigogneau, et al.Journal of Medicinal Chemistry|September 1, 1995
Synthesis and serotonergic activity of arylpiperazide derivatives of serotonin: potent agonists for 5-HT1D receptorsM Perez, C Fourrier, I Sigogneau, et al.Journal of Medicinal Chemistry|December 6, 1996
Serotonin dimers: application of the bivalent ligand approach to the design of new potent and selective 5-HT(1B/1D) agonistsS Halazy, M Perez, C Fourrier, et al.British Journal of Pharmacology|March 22, 2007
F15063, a potential antipsychotic with D2/D3 antagonist, 5-HT 1A agonist and D4 partial agonist properties. I. In vitro receptor affinity and efficacy profileA Newman-Tancredi, M-B Assié, J-C Martel, et al.The Journal of Nutrition, Health & Aging|September 28, 2019
Depression Severity as a Risk Factor of Sarcopenic Obesity in Morbidly Obese PatientsV Venant, M Pouget, C Lahaye, et al.Pageof 4